146 related articles for article (PubMed ID: 30560585)
1. MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival.
Liu Y; Li B; Yang X; Zhang C
J Cell Biochem; 2019 Dec; 120(12):19330-19337. PubMed ID: 30560585
[TBL] [Abstract][Full Text] [Related]
2. MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.
Huang HG; Luo X; Wu S; Jian B
Asian Pac J Cancer Prev; 2015; 16(12):4937-44. PubMed ID: 26163618
[TBL] [Abstract][Full Text] [Related]
3. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
Hu Y; Zhu Q; Tang L
PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
[TBL] [Abstract][Full Text] [Related]
4. CircMCTP2 enhances the progression of bladder cancer by regulating the miR-99a-5p/FZD8 axis.
Liu Y; Zhang K; Yang X
J Egypt Natl Canc Inst; 2024 Mar; 36(1):8. PubMed ID: 38494582
[TBL] [Abstract][Full Text] [Related]
5. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biomed Pharmacother; 2018 Dec; 108():1039-1047. PubMed ID: 30372804
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
7. miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells.
Tsai TF; Lin JF; Chou KY; Lin YC; Chen HE; Hwang TI
Onco Targets Ther; 2018; 11():239-252. PubMed ID: 29379304
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
9. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
Wu SH; Han L; Lu BC; Wang HY; Zheng CP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
[TBL] [Abstract][Full Text] [Related]
11. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.
Zhang ZW; Guo RW; Lv JL; Wang XM; Ye JS; Lu NH; Liang X; Yang LX
Biochem Biophys Res Commun; 2017 Apr; 486(2):414-422. PubMed ID: 28315335
[TBL] [Abstract][Full Text] [Related]
13. Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
Tsai TF; Chen PC; Lin YC; Chou KY; Chen HE; Ho CY; Lin JF; Hwang TI
Environ Toxicol; 2020 Jan; 35(1):47-54. PubMed ID: 31587482
[TBL] [Abstract][Full Text] [Related]
14. microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
Tamai M; Tatarano S; Okamura S; Fukumoto W; Kawakami I; Osako Y; Sakaguchi T; Sugita S; Yonemori M; Yamada Y; Nakagawa M; Enokida H; Yoshino H
Mol Oncol; 2022 Mar; 16(6):1329-1346. PubMed ID: 35148461
[TBL] [Abstract][Full Text] [Related]
15. The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis.
Peng H; Li H
Mol Carcinog; 2019 Aug; 58(8):1465-1480. PubMed ID: 31026378
[TBL] [Abstract][Full Text] [Related]
16. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development.
Cheng H; Xue J; Yang S; Chen Y; Wang Y; Zhu Y; Wang X; Kuang D; Ruan Q; Duan Y; Wang G
Oncotarget; 2017 Jul; 8(29):47984-47997. PubMed ID: 28624790
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
[TBL] [Abstract][Full Text] [Related]
19. MiR-99a-5p regulates proliferation, migration and invasion abilities of human oral carcinoma cells by targeting NOX4.
Shi Y; Bo Z; Pang G; Qu X; Bao W; Yang L; Ma Y
Neoplasma; 2017; 64(5):666-673. PubMed ID: 28592118
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]